Fetal fibronectin testing for reducing the risk of preterm birth
about
Home uterine monitoring for detecting preterm labour.Antenatal interventions to reduce preterm birth: an overview of Cochrane Systematic Reviews.Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).Critical appraisal and clinical utility of atosiban in the management of preterm labor.Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth.Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birthTransvaginal sonographic evaluation of the cervix in asymptomatic singleton pregnancy and management options in short cervix.Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysisAdipokinins in pregnancies at risk of preterm deliveryQuantitative fetal fibronectin to predict spontaneous preterm birth: a review.Blind vaginal fetal fibronectin swab for prediction of preterm birth.Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth.Preterm Labor and Birth Management: Recommendations from the European Association of Perinatal Medicine.
P2860
Q30235924-22AF0176-F7BB-4B2B-ABA8-6A4C5BA6F8EBQ30578125-20EDA3AC-6619-4E36-81E0-9742CC991721Q33499105-1893AAE7-7E64-40C5-9A8F-2B61874A2B39Q33500872-B4B14660-D056-4535-9C20-F9929DF4E8ABQ33817796-58C0D493-2475-451A-88FA-C985BE0B4F4CQ34356719-7E3CB7B5-5EE2-4622-96FA-41E056779281Q35703067-A738E223-F536-425D-B40D-AAC776C56637Q35864914-7B44E3AD-7DC6-478A-957A-CB6DC1219A2EQ36163612-DD5DD01B-83B2-474C-8B99-08FDACF01823Q36904789-E242015A-2B46-447D-AC31-5BB79F19B7C1Q38664900-38C80151-6D1A-4EFA-92F4-5425512D489BQ38999058-A0CE5C8A-8F11-4A44-9203-D7D896905906Q49790900-04FA923C-E536-408B-9EA4-2BB716970736Q53111929-3DF4C2D1-CE0C-465E-9399-49E9D8A71BA5
P2860
Fetal fibronectin testing for reducing the risk of preterm birth
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fetal fibronectin testing for reducing the risk of preterm birth
@ast
Fetal fibronectin testing for reducing the risk of preterm birth
@en
Fetal fibronectin testing for reducing the risk of preterm birth
@en-gb
Fetal fibronectin testing for reducing the risk of preterm birth
@nl
type
label
Fetal fibronectin testing for reducing the risk of preterm birth
@ast
Fetal fibronectin testing for reducing the risk of preterm birth
@en
Fetal fibronectin testing for reducing the risk of preterm birth
@en-gb
Fetal fibronectin testing for reducing the risk of preterm birth
@nl
prefLabel
Fetal fibronectin testing for reducing the risk of preterm birth
@ast
Fetal fibronectin testing for reducing the risk of preterm birth
@en
Fetal fibronectin testing for reducing the risk of preterm birth
@en-gb
Fetal fibronectin testing for reducing the risk of preterm birth
@nl
P2093
P2860
P1476
Fetal fibronectin testing for reducing the risk of preterm birth
@en
P2093
Edward Hayes
Jason K Baxter
John Visintine
P2860
P304
P356
10.1002/14651858.CD006843.PUB2
P577
2008-10-08T00:00:00Z